30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Shoulder Innovations Gains Clearance for InSet Plus Augmented Glenoids -

Shoulder Innovations received FDA 510(k) clearance to market InSet Plus™ augmented glenoids for the InSet™ Total Shoulder. The new glenoids feature an angled articular surface and are available in both 5° and 10° variants with multiple diameters to treat significant disability in degenerative, rheumatoid and traumatic disease of the glenohumeral joint and avascular necrosis of the humeral head. Studies have shown that the InSet Shoulder demonstrated an 87% reduction in implant micro-motion vs. conventional glenoid designs, with no complications, no cases of glenoid implant loosening and no revisions performed in the series at a mean 8.7-year follow-up.